Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GE4A
|
||||
Former ID |
DNC013215
|
||||
Drug Name |
N-butyl-2-(1H-indol-3-yl)-2-oxoacetamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528709] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H16N2O2
|
||||
Canonical SMILES |
CCCCNC(=O)C(=O)C1=CNC2=CC=CC=C21
|
||||
InChI |
1S/C14H16N2O2/c1-2-3-8-15-14(18)13(17)11-9-16-12-7-5-4-6-10(11)12/h4-7,9,16H,2-3,8H2,1H3,(H,15,18)
|
||||
InChIKey |
XTLXOIBNXHXNBR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [528709] | |
Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [528709] | ||
Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [528709] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.